DRKS00026962已完成未知
Proof of concept study to investigate bioavailability of two different Curcumin formulations in healthy subjects: a randomized, controlled, cross-over study
nternehmen zur Herstellung und Vertrieb von Nahrungsergänzungsmitteln0 个研究点目标入组 6 人开始时间: 2021年10月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 40 Years 至 65 Years(—)
- 性别
- All
入选标准
- •Healthy men and women
- •- BMI: 19 - 30 kg/m2
- •- Non-smoker
- •- Written consent to participate in the study
- •- Able and willing to follow the study procedure
排除标准
- •Main exclusion criteria:
- •- Relevant history or presence of any severe medical disorder, potentially interfering with this study
- •- Known allergy and hypersensitivity to ingredients of the study product
- •- Blood donation within 1 month prior to study start or during study
- •- Significant changes in lifestyle or medication (within last 3 months) or surgical intervention or surgical procedure such as bariatric surgery
- •- For this study clinically relevant abnormal laboratory, vital signs or physical findings at screening
- •- Extreme dietary regimes”: vegan lifestyle, weight loss diet with <1200 kcal/day for women and <1800 kcal for men
- •- Regular intake of drugs or supplements possibly interfering with this study within 2 weeks prior to study start or during the study (e.g. curcumin)
- •- Chronic intake of substances affecting blood coagulation, which in the investigator’s opinion would impact subject safety
- •- Subjects with history of drug, alcohol or other substance abuse, or other factors limiting their ability to co-operate during the study.
- •- Known pregnancy, breast feeding or intention to become pregnant during the study.
- •- Anticipating any planned changes in lifestyle for the duration of the study
研究者
相似试验
已完成
1 期
Study to assess the distribution in the blood of healthy volunteers of a new formulation of losartan compared with the marketed formulation Cozaar® administered under fasting conditionsBioavailability of a new formulation of losartanISRCTN16928142DPL Pharma S.p.A.16
进行中(未招募)
不适用
Comparison of blood concentrations of tapentadol from 4 prolonged release formulations (3 granule formulations and 1 tablet formulation) in healthy adult subjects.o medical condition to be investigated.MedDRA version: 17.0Level: LLTClassification code 10049475Term: Chronic painSystem Organ Class: 100000004867EUCTR2012-005499-33-DEGrünenthal GmbH
进行中(未招募)
1 期
Phase I Relative Bioavailability and food effect studyEUCTR2016-002895-29-DEBayer AG
进行中(未招募)
1 期
Phase I relative bioavailability and food effect studyEUCTR2016-002813-24-DEBayer AG
进行中(未招募)
不适用
A study to compare a pediatric tablet or suspension of elvitegravir verses the adult 150 mg tablet in healthy adult volunteersHuman Immunodeficiency Virus (HIV-1) InfectionMedDRA version: 17.1Level: LLTClassification code 10020192Term: HIV-1System Organ Class: 100000004862EUCTR2015-000725-37-Outside-EU/EEAGilead Sciences, Inc.78
